Ameriprise
ABCL icon

Ameriprise’s AbCellera Biologics ABCL Stock Holding History

Ameriprise’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-289,836
Closed -$858K – 3924
2024
Q2 		$858K Hold
289,836
– – ﹤0.01% 3214
2024
Q1 		$1.31M Sell
289,836
-50
-0% -$255 ﹤0.01% 3058
2023
Q4 		$1.66M Sell
289,886
-3,684
-1% -$17.1K ﹤0.01% 2966
2023
Q3 		$1.35M Buy
293,570
+341
+0.1% +$2.07K ﹤0.01% 3010
2023
Q2 		$1.89M Buy
293,229
+2,101
+0.7% +$14.3K ﹤0.01% 2899
2023
Q1 		$2.2M Buy
291,128
+47,846
+20% +$434K ﹤0.01% 2804
2022
Q4 		$2.46M Buy
+243,282
New +$2.81M ﹤0.01% 2714
2021
Q2 		– Sell
-524,690
Closed -$17.8M – 3881
2021
Q1 		$17.8M Buy
524,690
+216,547
+70% +$8.63M 0.01% 1407
2020
Q4 		$12.4M Buy
+308,143
New +$14.1M ﹤0.01% 1580

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return